Inventor

DUSZA JOHN P

US51 patents

⚠️ This page may combine multiple inventors who share the name “DUSZA JOHN P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DUSZA JOHN P

AMERICAN CYANAMID CO

Tricyclic benzazepine vasopressin antagonists

Tricyclic benzazepine vasopressin antagonists

N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas

[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines

Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones

Pyrazolo[1,5-a]pyrimidines and imidazo-[1,5-a]pyrimidines

N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto

4,5,6-substituted-N-(substituted-phenyl)-2-pyrimidinamines

4,5,6-substituted-N-(substituted-phenyl)-2-pyrimidinamines

3-Substituted-7-[3-(imidazol-1-yl)phenyl]-pyrazolo[1,5-a]pyrimidines

(3-amino-1H-pyrazol-4-yl) (aryl)methanones

Aryl and heteroaryl[[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]methanones

Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents

Tricyclic benzazepine vasopressin antagonists

N-(dialkylamino)methylene)-substituted pyrazolo(1,5-a)-pyrimidine-3-carboxamides and N-(dialkylamino)methylene-substituted-4,5-dihydropyrazolo-(1,5-a)-pyrimidine-3-carboxamides

4,5-dihydro and 4,5,6,7-tetrahydropyrazolo(1,5-A)-pyrimidines

Pyrazolo[1,5-a]pyrimidines

(Substituted-phenyl)-1,2,4-triazolo[4,3-a]-pyrimidines and (substituted-phenyl)-1,2,4-triazolo[1,5-a]pyrimidines

2-(substituted-1-piperazinyl)[1,2,4]triazolo[1,5-a]pyrimidines

1-(5-Amino-4H-1,2,4-triazol-3-yl)-4-substituted-piperazines

6- And 8-heteroaryl-1,2,4-triazolo[4,3-b]pyridazines

Imidazo[1,5-a]pyrimidines

Tricyclic benzazepine vasopressin antagonists

Method of making (3-amino-1H-pyrazol-4-yl) (aryl)methanones

Therapeutically active 3-amino-1-halogenated phenyl-2-pyrazolines and their C4 and C5 analogs

7-Heteroaryl[1,2,4]triazolo[1,5-a]pyrimidines

Therapeutically active 3-amino-1-phenyl(and substituted phenyl)-2-pyrazolines

Novel 3-substituted amino-1-substituted heteroaryl-2-pyrazolines

2-Pyridylhydrazides

N-((dialkylamino)methylene)-substituted pyrazolo (1,5-A)-pyrimidine-3-carboxamides and N-((dialkylamino)methylene)-substituted-4,5-dihydropyrazolo-(1,5-A)-pyrimidine-3-carboxamides

Phenyl imidazo[1,2-a]pyrimidines

Pyridyl imidazo[1,2-a]pyrimidines

Therapeutically active 3-substituted amino-1-phenyl and substituted phenyl-2-pyrazolines

Substituted phenyl-5-aminopyrazoles

Novel 3-substituted amino-1-heteroaryl-2-pyrazolines

4-Heteroarylimidazo-[1,5-A]pyrimidines

4,8-disubstituted-1,2-dihydro and 1,2,3,4-tetrahydroimidazo-[1,5-a] pyrimidines

N-substituted-N-[3-(1,2,4-triazolo-[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas

Process for the synthesis of α-[(dialkylamino)substituted-methylene]-β-oxo-(substituted)propanentriles

3-Trifluoroacetylamino-1-aryl-2-pyrazolines

N-substituted -N-(3-(1,2,4-triazolo-(4,3-b)pyridazin-6-yl)phenyl)alkanamides, carbamates and ureas

Heterocyclic substituted-amino-pyrazolines

Therapeutically active 3-amino-1-phenyl and substituted phenyl-2-pyrazolines

3-Trifluoroacetyl amino-1-aryl-2-pyrazolines

WYETH CORP

Biphenyl vasopressin agonists

Tricyclic vasopressin agonists

Cyclohexylphenyl vasopressin agonists

Biphenyl vasopressin agonists

Cyclohexylphenyl vasopressin agonists

Biphenyl vasopressin agonists